Strategy Driven

MAY 25, 2011

And when they don’t feel safe, they don’t take risks – and where there is no risk taken, there is less innovation, less ‘going the extra mile,’ and therefore, very little unexpected upside. In my book, I describe an incident that took place at a famous, fast-growing technology company. About the Author.

Company 62

Company Venture Capitalist Film Reputation 62

Harvard Business Review

JUNE 8, 2015

Pharmaceutical companies, buffeted by regulatory changes, new drug technologies that alter entry barriers and competition, price pressures, and an estimated 300,000 job cuts since 2000, seem to fit the popular narrative of large organizations unable to deal with disruptive forces.

Health Care 8

Health Care Venture Capitalist Strategic Fit Pharmaceuticals 8

Strategy Driven

MAY 25, 2011

And when they don’t feel safe, they don’t take risks – and where there is no risk taken, there is less innovation, less ‘going the extra mile,’ and therefore, very little unexpected upside. In my book, I describe an incident that took place at a famous, fast-growing technology company. About the Author.

Company 50

Company Venture Capitalist Film Reputation 50

Harvard Business Review

SEPTEMBER 23, 2011

Not to mention boardroom soap operas, front-page ethics scandals, and more changes of direction than a surfer in a hurricane. What's important about HP is what it says about how hard it is for any organization to maintain its leadership position from one generation of technology and markets and culture to the next.

Venture Capitalist 14

Venture Capitalist CEO Long-term Magazine 14